| Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens P Larsson, H Engqvist, J Biermann, E Werner Rönnerman, ... Scientific reports 10 (1), 5798, 2020 | 170 | 2020 |
| Immunohistochemical validation of COL3A1, GPR158 and PITHD1 as prognostic biomarkers in early-stage ovarian carcinomas H Engqvist, TZ Parris, A Kovács, S Nemes, E Werner Rönnerman, ... BMC cancer 19, 1-12, 2019 | 48 | 2019 |
| Validation of novel prognostic biomarkers for early-stage clear-cell, endometrioid and mucinous ovarian carcinomas using immunohistochemistry H Engqvist, TZ Parris, A Kovács, EW Rönnerman, K Sundfeldt, P Karlsson, ... Frontiers in oncology 10, 162, 2020 | 30 | 2020 |
| Genome-wide multi-omics profiling of the 8p11-p12 amplicon in breast carcinoma TZ Parris, EW Rönnerman, H Engqvist, J Biermann, K Truvé, S Nemes, ... Oncotarget 9 (35), 24140, 2018 | 22 | 2018 |
| Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes H Engqvist, TZ Parris, J Biermann, EW Rönnerman, P Larsson, ... Scientific reports 10 (1), 7946, 2020 | 18 | 2020 |
| Clonal relatedness in tumour pairs of breast cancer patients J Biermann, TZ Parris, S Nemes, A Danielsson, H Engqvist, ... Breast Cancer Research 20, 1-16, 2018 | 15 | 2018 |
| Transcriptomic and genomic profiling of early-stage ovarian carcinomas associated with histotype and overall survival H Engqvist, TZ Parris, EW Rönnerman, EMV Söderberg, J Biermann, ... Oncotarget 9 (80), 35162, 2018 | 13 | 2018 |
| A 17-marker panel for global genomic instability in breast cancer J Biermann, S Nemes, TZ Parris, H Engqvist, EW Rönnerman, A Kovács, ... Genomics 112 (2), 1151-1161, 2020 | 10 | 2020 |
| Radiation‐induced genomic instability in breast carcinomas of the Swedish hemangioma cohort J Biermann, B Langen, S Nemes, E Holmberg, TZ Parris, ... Genes, Chromosomes and Cancer 58 (9), 627-635, 2019 | 6 | 2019 |
| Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens. Sci Rep. 2020; 10: 5798 P Larsson, H Engqvist, J Biermann, E Werner Ronnerman, ... | 6 | |
| Optimization of cell viability assays to improve replicability and reproducibility of cancer drug sensitivity screens. Sci Rep 10 (1): 5798 P Larsson, H Engqvist, J Biermann, EW Ronnerman, E Forssell-Aronsson, ... | 5 | 2020 |
| Pan-cancer analysis of genomic and transcriptomic data reveals the prognostic relevance of human proteasome genes in different cancer types P Larsson, D Pettersson, H Engqvist, E Werner Rönnerman, ... BMC cancer 22 (1), 993, 2022 | 3 | 2022 |
| A novel 18-marker panel predicting clinical outcome in breast cancer J Biermann, S Nemes, TZ Parris, H Engqvist, EW Rönnerman, ... Cancer Epidemiology, Biomarkers & Prevention 26 (11), 1619-1628, 2017 | 1 | 2017 |
| Novel biomarkers associated with histotype and clinical outcome in early-stage ovarian carcinoma H Engqvist | | 2020 |
